Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

Key facts

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Principal Investigator

Paul M Hwang, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Intervention

Nicotinamide Riboside (NR)(dietary_supplement)

Enrollment

1 enrolled

Eligibility

18-70 years · All sexes

Timeline

2019 – 2019

Study locations (1)

• National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Li-Fraumeni syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06712095
  Video Capsule Examination in Patients With Lynch Syndrome
  Royal Marsden NHS Foundation Trust
• RECRUITINGPHASE2NCT06088030
  Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
  Yang Li
• RECRUITINGNCT05126810
  Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
  M.D. Anderson Cancer Center
• RECRUITINGNCT04541654
  Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
  Dana-Farber Cancer Institute
• RECRUITINGNCT04982744
  Registry of Li Fraumeni and Li Fraumeni Like Syndromes
  Istituto Ortopedico Rizzoli
• RECRUITINGNCT04367246
  Li-Fraumeni Syndrome/TP53 Biobank
  Abramson Cancer Center at Penn Medicine
• ENROLLING BY INVITATIONNANCT03176836
  Li-Fraumeni Syndrome Imaging Study
  The Hospital for Sick Children
• ACTIVE NOT RECRUITINGNANCT02950987
  Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
  Dana-Farber Cancer Institute

See all trials for Li-Fraumeni syndrome →